Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/27/23 16:15 | 10/25/23 | ALGS | Health | BioPrd | Biological Products, (No Diag | Nuechterlein Carole | CA | DT | P.d | 6,004 | 0.7568 | 0 | 7,934 | 257 | 11,026 | I | |||||||||||||||
10/22/20 16:31 | 10/20/20 | ALGS | Health | BioPrd | Biological Products, (No Diag | Novo Holdings A/s | G7 | T | P.d | 3,000 | 15.00 | 0 | 200 | 8 | 2,615 | D | |||||||||||||||
10/20/20 17:00 | 10/20/20 | ALGS | Health | BioPrd | Biological Products, (No Diag | Woiwode Thomas | CA | D | P.d | 3,000 | 15.00 | 0 | 200 | 30 | 862 | I | |||||||||||||||
10/20/20 16:59 | 10/20/20 | ALGS | Health | BioPrd | Biological Products, (No Diag | Vivo Capital Viii, LLC | CA | T | P.d | 8,250 | 15.00 | 0 | 550 | 18 | 3,547 | I | |||||||||||||||
10/20/20 16:58 | 10/20/20 | ALGS | Health | BioPrd | Biological Products, (No Diag | Versant Venture Capital Vi, L.P. | CA | T | P.d | 3,000 | 15.00 | 0 | 200 | 6 | 3,292 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |